ALLOGENE THERAPEUTICS INC (ALLO)
US0197701065 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -327.26M | -332.63M | -257.01M | -250.22M | -184.59M | |||
| Depreciation Amortization | 14.20M | 14.30M | 10.45M | 7.59M | 5.02M | |||
| Change In Working Capital | -15.30M | 3.71M | -32.09M | 53.92M | -7.21M | |||
| Other non cash items | 90.64M | 94.11M | 93.83M | 73.62M | 49.43M | |||
| OPERATING CASH FLOW | -237.73M | -220.52M | -184.81M | -115.09M | -137.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.52M | -5.19M | -21.45M | -65.96M | -50.79M | |||
| Other Investing Activity | 164.81M | 111.35M | 185.10M | -439.17M | 214.88M | |||
| INVESTING CASH FLOW | 163.29M | 106.16M | 163.66M | -505.12M | 164.08M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 95.69M | 2.95M | 11.96M | 633.59M | 58.96M | |||
| FINANCING CASH FLOW | 95.69M | 2.95M | 11.96M | 633.59M | 58.96M | |||
| CHANGE IN CASH | 21.25M | -111.41M | -9.19M | 13.38M | 85.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -237.73M | -220.52M | -184.81M | -115.09M | -137.35M | |||
| Capital Expenditure | -1.52M | -5.19M | -21.45M | -65.96M | -50.79M | |||
| FREE CASH FLOW | -239.25M | -225.71M | -206.26M | -181.05M | -188.14M | |||
All data in USD